MUC5B变异与视觉和定量检测的临床前肺纤维化相关
研究纳入494名家族性间质性肺炎(FIP)患者的一级亲属,评估临床前肺纤维化(PrePF)的患病率及危险因素。视觉CT评估的PrePF患病率为15.6%(95%CI 12.6-19.0),深度学习定量CT分析具有较高的判别敏感性。PrePF与年龄、男性、吸烟史及MUC5B启动子变异rs35705950相关,MUC5B变异携带者定量CT纤维化评分更高。
要点
- FIP患者一级亲属中PrePF患病率为15.6%(95%CI 12.6-19.0)
- PrePF者更年长、男性多、吸烟多、MUC5B变异频率更高
- 定量CT分析可检测视觉评估的PrePF,敏感性较高
核心结论
- FIP患者亲属中PrePF常见,其患病率随年龄和MUC5B启动子变异存在而增加。
- 定量CT分析可检测这些影像学异常。
研究设计与样本
- 研究纳入494名来自263个FIP家族的40岁以上一级亲属,均自认为未患肺纤维化,接受胸部CT检查。
- 图像进行视觉评估,并使用深度学习算法定量肺纤维化,同时检测MUC5B和TERT常见IPF风险变异。
主要发现
- 视觉CT评估的PrePF患病率为15.6%(95%CI 12.6-19.0)。
- 与视觉CT评估相比,深度学习定量CT分析的敏感性为84%(95%CI 0.72-0.89),另一敏感性为86%(95%CI 0.83-0.89)。
- PrePF者年龄更大(65.9,SD 10.1岁) vs 无纤维化者(55.8,SD 8.7岁),男性比例更高(49% vs 37%),吸烟史更多(44% vs 27%),MUC5B变异rs35705950次要等位基因频率更高(0.29 vs 0.21)。
- MUC5B变异携带者定量CT纤维化评分更高(平均差异0.36%),控制年龄和性别后差异仍显著。
临床怎么用
- 对FIP患者一级亲属可考虑CT筛查以发现PrePF。
- MUC5B变异携带者及年龄较大、有吸烟史者风险更高,应加强监测。
- 定量CT分析可作为视觉评估的辅助工具检测早期纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Relatives of patients with familial interstitial pneumonia (FIP) are at increased risk for pulmonary fibrosis. We assessed the prevalence and risk factors for preclinical pulmonary fibrosis (PrePF) in first-degree relatives of patients with FIP and determined the utility of deep learning in detecting PrePF on CT. METHODS: First-degree relatives of patients with FIP over 40 years of age who believed themselves to be unaffected by pulmonary fibrosis underwent CT scans of the chest. Images were visually reviewed, and a deep learning algorithm was used to quantify lung fibrosis. Genotyping for common idiopathic pulmonary fibrosis risk variants in MUC5B and TERT was performed. FINDINGS: In 494 relatives of patients with FIP from 263 families of patients with FIP, the prevalence of PrePF on visual CT evaluation was 15.6% (95% CI 12.6 to 19.0). Compared with visual CT evaluation, deep learning quantitative CT analysis had 84% sensitivity (95% CI 0.72 to 0.89) and 86% sensitivity (95% CI 0.83 to 0.89) for discriminating subjects with visual PrePF diagnosis. Subjects with PrePF were older (65.9, SD 10.1 years) than subjects without fibrosis (55.8 SD 8.7 years), more likely to be male (49% vs 37%), more likely to have smoked (44% vs 27%) and more likely to have the MUC5B promoter variant rs35705950 (minor allele frequency 0.29 vs 0.21). MUC5B variant carriers had higher quantitative CT fibrosis scores (mean difference of 0.36%), a difference that remains significant when controlling for age and sex. INTERPRETATION: PrePF is common in relatives of patients with FIP. Its prevalence increases with age and the presence of a common MUC5B promoter variant. Quantitative CT analysis can detect these imaging abnormalities.
引用
- Mathai SK, Humphries S, Kropski JA, et al. MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis. Thorax. 2019. PMID: 31558622. doi:10.1136/thoraxjnl-2018-212430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。